Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
PROTEOMICS – Clinical Applications, 2022Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
He B., Huang Z., Huang C. et al.
Molecular Metabolism, 2022Gene-based whole genome sequencing meta-analysis of 250 circulating proteins in three isolated European populations
Gilly A., Klaric L., Park Y. et al.
Olink Target 96
Biochemical and Biophysical Research Communications, 2022A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates
Sjoqvist S., Otake K.
Cell, 2022Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Wei T., Chandy M., Nishiga M. et al.
American Journal of Respiratory Cell and Molecular Biology, 2022Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform
Mickael C., Kheyfets V., Langouët-Astrié C. et al.
Translational Psychiatry, 2022Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders
Kuan P., Yang X., Kotov R. et al.
Frontiers in Aging Neuroscience, 2022The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease
Nieraad H., de Bruin N., Arne O. et al.
Olink Target 96 Mouse
Experimental Dermatology, 2022Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris
Koschitzky M., Navrazhina K., Garshick M. et al.
International Journal of Obesity, 2022Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study
Maalmi H., Herder C., Huth C. et al.
Biomedicines, 2022Cerebrospinal Fluid in Classical Trigeminal Neuralgia: An Exploratory Study on Candidate Biomarkers
Svedung Wettervik T., Folkvaljon D., Gordh T. et al.
Research and Practice in Thrombosis and Haemostasis, 2022Proteomics in thrombosis research
Edfors F., Iglesias M., Butler L. et al.
Expert Review of Proteomics, 2022Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications
Dayon L., Cominetti O., Affolter M.
The American Journal of Pathology, 2022Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
Price D., Benedetti E., Hoffman K. et al.
Translational Neurodegeneration, 2022Advances in the development of new biomarkers for Alzheimer’s disease
Klyucherev T., Olszewski P., Shalimova A. et al.
BJS Open, 2022Preoperative biomarkers related to inflammation may identify high-risk anastomoses in colorectal cancer surgery: explorative study
Holmgren K., Jonsson P., Lundin C. et al.
European Stroke Journal, 2022A novel biomarker panel index improves risk stratification after ischemic stroke
Bicvic A., Scherrer N., Schweizer J. et al.
Cell Reports, 2022Systems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria
Lautenbach M., Yman V., Silva C. et al.
International Journal of Rheumatic Diseases, 2022Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study
Ferreira M., Fonseca T., Costa R. et al.
Journal for ImmunoTherapy of Cancer, 2022Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa
Tsai Y., Strauss J., Toney N. et al.
Communications Biology, 2022Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
Svensson Akusjärvi S., Krishnan S., Jütte B. et al.
4265 publications
Items per page
3381-3400 of 4265 publications